Prevention of Venous Thromboembolism after Hospital Discharge Continued Pharmacological Prophylaxis versus No Prophylaxis in Patients Undergoing Total Hip Replacement (original ) (raw )Benefit–risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty
B. Levitan
Vascular Health and Risk Management, 2014
View PDFchevron_right
Venous Thromboembolism Prophylaxis: Need for Continuous Assessment Due to Changes in Risk During the Same Hospitalization
thomas kingsley
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, 2020
View PDFchevron_right
Impact of venous thromboembolism on clinical management and therapy after hip and knee arthroplasty
William Fisher
Canadian Journal of Surgery, 2011
View PDFchevron_right
Asia-Pacific venous thromboembolism consensus in knee and hip arthroplasty and hip fracture surgery: Part 2. Mechanical venous thromboembolism prophylaxis
Ngai Nung Lo
Knee Surgery & Related Research, 2021
View PDFchevron_right
Pharmacologic Prophylaxis for Venous Thromboembolism Among Patients With Total Joint Replacement
Daniel Nisi
American Journal of Therapeutics, 2016
View PDFchevron_right
Comparative study of extended versus short term thromboprophylaxis in patients undergoing elective total hip and knee arthroplasty in Indian population
Ratheesh Kumar
Indian Journal of Orthopaedics, 2013
View PDFchevron_right
Bleeding and thromboembolism risk of standard antithrombotic prophylaxis after hip or knee replacement within an enhanced recovery program
aymard de ladoucette
Orthopaedics & Traumatology: Surgery & Research, 2020
View PDFchevron_right
A review of the evidence for and against thromboprophylaxis in total hip replacement
Mahiben Maruthappu
Acta orthopaedica Belgica
View PDFchevron_right
Evaluating the effectiveness of using enoxaparin to prevent venous thromboembolism in hip replacement patients: A retrospective cohort study
Dong Kha
Biomedical Research and Therapy, 2021
View PDFchevron_right
Prevention of venous thromboembolism after major orthopedic surgery: summing up evidence about old and new antithrombotic agents
Henri Bounameaux
Journal of Thrombosis and Haemostasis, 2004
View PDFchevron_right
Impact of thromboprophylaxis guidelines on clinical outcomes following total hip and total knee replacement
Henry Henk , Rita Selby
Thrombosis research, 2012
View PDFchevron_right
Cost-Effectiveness of Venous Thromboembolism Prophylaxis after Total Hip Replacement
Juan Arcelus
Phlebology, 2002
View PDFchevron_right
Postdischarge thromboprophylaxis and mortality risk after hip-or knee-replacement surgery
hacene nedjar
Canadian Medical Association Journal, 2008
View PDFchevron_right
Venous thromboembolism in 13 Indonesian patients undergoing major orthopedic surgery
Ifran Saleh
Medical Journal of Indonesia, 2009
View PDFchevron_right
Venous thromboprophylaxis in general surgery ward admissions: strategies for improvement
M. Milberg
International Journal for Quality in Health Care, 2012
View PDFchevron_right
Low dose compared to variable dose Warfarin and to Fondaparinux as prophylaxis for thromboembolism after elective hip or knee replacement surgery; a randomized, prospective study
Laura Hou
Thrombosis Journal, 2015
View PDFchevron_right
Thromboprophylaxis and death after total hip replacement
Sophia Kunze
The Journal of Bone and Joint Surgery, 1996
View PDFchevron_right
Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients
ANA THEREZA ROCHA
Vascular Health and …, 2007
View PDFchevron_right
Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacement
Agg Turpie
The Journal of Bone and Joint Surgery. British volume, 2009
View PDFchevron_right
Oral thromboprophylaxis following total hip replacement: the issue of compliance
C. Vielpeau
Orthopaedics & traumatology, surgery & research : OTSR, 2012
View PDFchevron_right
Economics of Thromboprophylaxis in Total Hip Replacement Surgery
Jeff Harrison
PharmacoEconomics, 1997
View PDFchevron_right
The influence of oral anticoagulation therapy on deep vein thrombosis rates four weeks after total hip replacement
jose reyna
Journal of Vascular Surgery, 1999
View PDFchevron_right
A Review of the Preventive Strategies for Venous Thromboembolism in Hospitalized Patients
Heritage Kristilere
Cureus, 2023
View PDFchevron_right
Safe practice for patients receiving anticoagulant therapy
Jane Harden
Nursing Standard, 2010
View PDFchevron_right
Compliance of dutch orthopedic departments with national guidelines on thromboprophylaxis
Harmen Ettema
Acta Orthopaedica, 2005
View PDFchevron_right
Venous Thromboembolic Disease After Hip Surgery
Samuel Berkman
Clinical Orthopaedics and Related Research, 1989
View PDFchevron_right
Venous Thromboembolism (VTE) Prophylaxis for Hip and Knee Arthroplasty: Changing Trends
Nadia Nastassia Ifran
Current Reviews in Musculoskeletal Medicine, 2014
View PDFchevron_right
Out of hospital antithrombotic prophylaxis after total hip replacement: low-molecular-weight heparin, warfarin, aspirin or nothing? A cost-effectiveness analysis
Henri Bounameaux
Thrombosis and haemostasis, 2002
View PDFchevron_right